Keurig Dr Pepper Inc (NYSE:KDP) insider Brian Andrew Loucks purchased 18,554 shares of the stock in a transaction on Wednesday, August 14th. The stock was acquired at an average cost of $28.31 per share, for a total transaction of $525,263.74. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of KDP stock traded up $0.36 during mid-day trading on Thursday, hitting $27.78. 503,599 shares of the stock were exchanged, compared to its average volume of 2,759,633. The stock’s fifty day moving average price is $28.61. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.23 and a current ratio of 0.33. Keurig Dr Pepper Inc has a 52-week low of $22.19 and a 52-week high of $31.06. The company has a market capitalization of $38.90 billion, a P/E ratio of 26.71, a PEG ratio of 1.53 and a beta of 0.46.
Keurig Dr Pepper (NYSE:KDP) last posted its earnings results on Thursday, August 8th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.01. Keurig Dr Pepper had a net margin of 8.82% and a return on equity of 7.15%. The business had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.86 billion. During the same period in the prior year, the company posted $1.30 EPS. The company’s revenue for the quarter was up 196.3% on a year-over-year basis. On average, equities research analysts anticipate that Keurig Dr Pepper Inc will post 1.22 EPS for the current fiscal year.
Several equities research analysts have commented on the stock. Bank of America upped their price target on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the company a “buy” rating in a report on Friday, August 9th. ValuEngine raised shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Royal Bank of Canada set a $31.00 price target on shares of Keurig Dr Pepper and gave the company a “buy” rating in a report on Friday, August 9th. Morgan Stanley set a $24.00 price target on shares of Keurig Dr Pepper and gave the company a “sell” rating in a report on Friday, August 9th. Finally, Credit Suisse Group started coverage on shares of Keurig Dr Pepper in a research note on Wednesday, July 17th. They set a “neutral” rating and a $27.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. Keurig Dr Pepper presently has an average rating of “Buy” and an average price target of $29.24.
About Keurig Dr Pepper
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Featured Story: Understanding Price to Earnings Ratio (PE)
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.